| 000959 | 首钢股 | -0.82 | 0.64 | 307.47 | 1.31 | | --- | --- | --- | --- | --- | --- | | | 份 | | | | | | 600983 | 惠而浦 | 2.41 | 0.42 | 127.33 | 4.08 | | 002010 | 传化智 | 4.65 | 3.05 | 74.39 | 0.15 | | | 联 | | | | | | 688796 | 百奥赛 | 4.66 | 17.73 | -244.72 | -0.70 | | | 图 | | | | | | 300620 | 光库科 | 3.15 | 5.54 | -5119.47 | -2.48 | | | 技 | | | | | 资金面上看，今日2025年报预增概念板块获主力资金净流入16.28亿元，其中，10股获主力资金净流 入，5股主力资金净流入超3000万元，净流入资金居首的是紫金矿业，今日主力资金净流入9.02亿元， 净流入资金居前的还有盐湖股份、C强一、大洋生物等，主力资金分别净流入5.08亿元、1.27亿元、 8189.03万元。 资金流入比率方面， ...

牙科医疗概念资金流入榜 截至1月5日收盘，牙科医疗概念上涨4.97%，位居概念板块涨幅第5，板块内，25股上涨，迈普医学、 康拓医疗、乐普医疗等20%涨停，春立医疗、海利生物、奕瑞科技等涨幅居前，分别上涨8.87%、 7.87%、6.51%。跌幅居前的有朗姿股份、维宏股份、东方精工等，分别下跌0.98%、0.98%、0.83%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 脑机接口 | 13.70 | 海南自贸区 | -2.93 | | 高压氧舱 | 7.01 | 免税店 | -1.08 | | 血氧仪 | 5.65 | 自由贸易港 | -0.94 | | 2025年报预增 | 5.16 | 猪肉 | -0.28 | | 牙科医疗 | 4.97 | 网约车 | -0.05 | | 芬太尼 | 4.74 | 赛马概念 | -0.05 | | 细胞免疫治疗 | 4.73 | 养鸡 | -0.04 | | 云游戏 | 4.64 | 冰雪产业 | 0.09 | | 辅助生殖 | 4.45 | 减速器 | 0.11 ...

截至1月5日收盘，牙科医疗概念上涨4.97%，位居概念板块涨幅第5，板块内，25股上涨，迈普医学、 康拓医疗、乐普医疗等20%涨停，春立医疗、海利生物、奕瑞科技等涨幅居前，分别上涨8.87%、 7.87%、6.51%。跌幅居前的有朗姿股份、维宏股份、东方精工等，分别下跌0.98%、0.98%、0.83%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 脑机接口 | 13.70 | 海南自贸区 | -2.93 | | 高压氧舱 | 7.01 | 免税店 | -1.08 | | 血氧仪 | 5.65 | 自由贸易港 | -0.94 | | 2025年报预增 | 5.16 | 猪肉 | -0.28 | | 牙科医疗 | 4.97 | 网约车 | -0.05 | | 芬太尼 | 4.74 | 赛马概念 | -0.05 | | 细胞免疫治疗 | 4.73 | 养鸡 | -0.04 | | 云游戏 | 4.64 | 冰雪产业 | 0.09 | | 辅助生殖 | 4.45 | 减速器 | 0.11 | | 存储芯片 | ...

芬太尼概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 600079 | ST人福 | 2.26 | 1.67 | 6989.38 | 14.70 | | 600511 | 国药股 份 | 1.04 | 1.10 | 1047.55 | 5.96 | | 600420 | 国药现 代 | 1.39 | 0.72 | 756.81 | 7.69 | | 600285 | 羚锐制 药 | 4.88 | 2.83 | 479.39 | 1.39 | | 300482 | 万孚生 物 | 2.13 | 1.25 | 441.22 | 4.09 | | 688298 | 东方生 物 | 5.12 | 1.59 | 238.15 | 3.05 | | 002262 | 恩华药 业 | 1.12 | 1.29 | -105.69 | -0.38 | 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | ...

今日涨跌幅居前的概念板块 高压氧舱概念资金流出榜 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 002173 | 创新医疗 | -2.40 | 7.97 | -13214.48 | | 002430 | 杭氧股份 | 0.26 | 2.59 | -3930.64 | | 300143 | 盈康生命 | -1.66 | 0.92 | -1234.95 | | 601567 | 三星医疗 | -1.38 | 1.19 | -787.45 | | 000516 | 国际医学 | -0.45 | 0.42 | -724.36 | | 688425 | 铁建重工 | 0.77 | 0.60 | -473.53 | | 605001 | 威奥股份 | -0.66 | 1.52 | 14.64 | | 600257 | 大湖股份 | -1.62 | 2.68 | 46.88 | | 000919 | 金陵药业 | 2.93 | 4.28 | 204.60 | | 002172 | 澳洋健康 | -1.91 | ...

来源：新浪证券-红岸工作室 12月26日，春立医疗跌1.82%，成交额2004.30万元，换手率0.29%，总市值90.94亿元。 异动分析 医疗器械概念+智能医疗+牙科医疗+专精特新+京津冀一体化 2、2024年10月9日互动易：我公司是一家专注于骨科医疗器械领域的高新技术企业，产品涵盖关节类、 脊柱类、运动医学类、创伤类等全系列骨科产品。同时公司已经取得了髋关节手术机器人、膝关节手术 机器人等产品的注册证，以及手术规划的"医学图像处理软件"。这些产品和软件的开发表明公司在智能 医疗等领域进行的布局和研发投入。 3、国内领先的骨科医疗器械厂商，春立医疗主营业务系植入性骨科医疗器械的研发、生产与销售，包 括口腔金属和隐形正畸 口腔种植和修复。 公司拟设计多孔钽定制个体化牙种植体产品并完成生产转 换， 目前处于设计送检阶段。 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部国家级专 精特新小巨人 ...

Core Viewpoint - Spring Medical is a leading domestic orthopedic medical device manufacturer, focusing on the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2][5] Company Overview - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, is located in Tongzhou District, Beijing. The company specializes in implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [7][8] - The company's product portfolio includes hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal internal fixation systems [5][8] Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%. The net profit attributable to the parent company was 192 million yuan, with a year-on-year increase of 213.21% [8] - Since its A-share listing, the company has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [8] Market Position and Recognition - Spring Medical has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is the highest honor for small and medium-sized enterprises in China, indicating its strong market position and innovation capabilities [3][5] - The company has obtained registration certificates for hip and knee surgical robots, as well as medical image processing software for surgical planning, showcasing its investment in smart medical technology [2][3] Shareholder Information - As of September 30, 2025, the number of shareholders for Spring Medical was 6,164, an increase of 4.12% from the previous period. The average circulating shares per person decreased by 3.95% to 46,906 shares [8][9] - Notable new shareholders include Hong Kong Central Clearing Limited and China Europe Economic Selection Mixed A, holding 2.9585 million and 2.8326 million shares, respectively [9]

Core Viewpoint - Spring Medical experienced a decline of 5.18% on November 21, with a trading volume of 61.44 million yuan and a market capitalization of 9.275 billion yuan [1] Company Overview - Spring Medical is a leading domestic orthopedic medical device manufacturer, focusing on the research, production, and sales of implantable orthopedic medical devices, including oral metal and invisible orthodontics, as well as oral implants and restorations [2][5] - The company is recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong innovation capabilities and high market share in niche markets [3] - The company is located in Tongzhou District, Beijing, and was established on February 12, 1998, with its public listing on December 30, 2021 [7][8] Product and Market Position - Spring Medical's main products include joint prosthetics and spinal implants, covering major human joints such as hip, knee, shoulder, and elbow, along with a full range of spinal internal fixation systems [2][8] - The company has obtained registration certificates for surgical robots for hip and knee joint surgeries, as well as medical image processing software for surgical planning, indicating its investment in smart medical technology [2][3] Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a year-on-year increase of 213.21% [8] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [9] Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Spring Medical was 6,164, an increase of 4.12% from the previous period, while the average circulating shares per person decreased by 3.95% [8] - The stock has seen a net outflow of 4.90 million yuan from major funds today, with a continuous reduction in major fund holdings over the past three days [4][5]

Core Viewpoint - Spring Medical experienced a decline of 1.21% on November 13, with a trading volume of 101 million yuan and a market capitalization of 10.61 billion yuan [1] Group 1: Company Overview - Spring Medical is a leading domestic manufacturer of orthopedic medical devices, focusing on the research, production, and sales of implantable orthopedic medical devices, including oral metal and invisible orthodontics, as well as oral implants and restorations [2][5] - The company has developed a customized porous tantalum dental implant product, which is currently in the design and inspection phase [2] - Spring Medical's main products include joint prosthetics and spinal implants, covering major human joints such as hip, knee, shoulder, and elbow, along with a full range of spinal internal fixation systems [2][5] Group 2: Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, reflecting a year-on-year increase of 213.21% [8] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [8] Group 3: Market Position and Recognition - Spring Medical has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is the highest honor for small and medium-sized enterprises in China, indicating its strong market position and innovation capabilities [3] - The company is located in the Tongzhou Economic Development Zone in Beijing and was established on February 12, 1998, with its listing date on December 30, 2021 [7]

Core Viewpoint - Spring Medical experienced a decline of 2.38% in stock price on November 7, with a trading volume of 83.6 million yuan and a total market capitalization of 10.21 billion yuan [1] Company Overview - Spring Medical is a leading domestic manufacturer of orthopedic medical devices, focusing on the research, production, and sales of implantable orthopedic medical devices, including oral metal and invisible orthodontics, as well as oral implants and restorations [2][5] - The company is recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong innovation capabilities and high market share in niche markets [3] - The company is located in Tongzhou District, Beijing, and was established on February 12, 1998, with its stock listed on December 30, 2021 [7] Product Portfolio - Spring Medical's main products include joint prosthetics and spinal implants, covering major human joints such as hip, knee, shoulder, and elbow, as well as a full range of spinal internal fixation systems [2][8] - The company has developed products such as hip and knee surgical robots and medical image processing software for surgical planning, indicating its investment in smart medical technology [2][3] Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a year-on-year increase of 213.21% [8] - Since its A-share listing, the company has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [8] Shareholder Structure - As of September 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited and China Europe Economic Selection Mixed A, both of which are new shareholders [9]